SCHEMBL30486608

SCHEMBL30486608

Fc1ccc(Br)c2c1OCCO2

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.33
MAOB P27338 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25346478 1.00 EGFR (0.33) EGFRMAOB
SCHEMBL197752 0.85 ITGB2 (0.36) MAOB
SCHEMBL18862586 0.77 ALDH1A1 (0.32)
SCHEMBL18797086 0.77 ABCC9 (0.33)
SCHEMBL21752368 0.75 ACHE (0.35)
SCHEMBL27631611 0.73 HTR2A (0.33) EGFRMAOB
SCHEMBL29661294 0.73 MAPT (0.35)
SCHEMBL17040763 0.73
SCHEMBL17041206 0.73 MAPT (0.35)
SCHEMBL21752292 0.71 LMNA (0.39) MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119212994-A Pyrazolopyrazine compounds as SHP2 inhibitors 建新公司 2024-12-27 CN disclosed
EP-4448526-A1 PYRAZOLOPYRAZINE COMPOUNDS AS SHP2 INHIBITORS GENZYME CORPORATION (US) 2024-10-23 EP disclosed
WO-2023114954-A1 PYRAZOLOPYRAZINE COMPOUNDS AS SHP2 INHIBITORS GENZYME CORPORATION (US) 2023-06-22 WO disclosed